[1]
M. Figueroa-Gaspar, E. Marín-Mendoza, Érika Chávez-Briseño, and A. A. Arredondo-López, “Cost Effectiveness of type 2 diabetes treatment at first level of care”, HS, vol. 21, no. 2, pp. 204–213, Apr. 2022, doi: 10.19136/hs.a21n2.4672.